Martingale Asset Management L P Bristol Myers Squibb CO Transaction History

Martingale Asset Management L P

$4.56 Billion
Q2 2024

A detailed history of Martingale Asset Management L P transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Martingale Asset Management L P holds 255,281 shares of BMY stock, worth $13.6 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

255,281

Previous 466,827 45.32%

Holding current value

$13.6 Million

Previous $25.3 Million 58.13%

% of portfolio

0.23%

Previous 0.51%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$40.25 - $52.99 $8.51 Million - $11.2 Million	-211,546 Reduced 45.32%	255,281 $10.6 Million
Q1 2024 May 14, 2024	SELL	$47.98 - $54.4 $2.88 Million - $3.27 Million	-60,079 Reduced 11.4%	466,827 $25.3 Million
Q4 2023 Feb 12, 2024	SELL	$48.48 - $57.85 $7.86 Million - $9.38 Million	-162,216 Reduced 23.54%	526,906 $27 Million
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $1.14 Million - $1.28 Million	-19,716 Reduced 2.78%	689,122 $40 Million
Q2 2023 Aug 11, 2023	SELL	$63.71 - $70.74 $1.42 Million - $1.57 Million	-22,227 Reduced 3.04%	708,838 $45.3 Million
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $88,642 - $100,540	1,349 Added 0.18%	731,065 $50.7 Million
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $5.34 Million - $6.33 Million	-78,011 Reduced 9.66%	729,716 $52.5 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $3,092 - $1.83 Million	-23,790 Reduced 2.86%	807,727 $57.4 Million
Q2 2022 Aug 11, 2022	SELL	$72.62 - $79.98 $8.54 Million - $9.4 Million	-117,567 Reduced 12.39%	831,517 $64 Million
Q1 2022 May 12, 2022	SELL	$61.48 - $73.72 $5.91 Million - $7.09 Million	-96,147 Reduced 9.2%	949,084 $69.3 Million
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $1.83 Million - $2.13 Million	-34,106 Reduced 3.16%	1,045,231 $65.2 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $8.12 Million - $9.51 Million	-137,269 Reduced 11.28%	1,079,337 $63.9 Million
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $2.3 Million - $2.5 Million	-37,121 Reduced 2.96%	1,216,606 $81.3 Million
Q1 2021 May 13, 2021	BUY	$59.34 - $66.74 $1.19 Million - $1.33 Million	19,985 Added 1.62%	1,253,727 $79.1 Million
Q4 2020 Feb 10, 2021	BUY	$57.74 - $65.43 $8.83 Million - $10 Million	152,848 Added 14.14%	1,233,742 $76.5 Million
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $12.2 Million - $13.5 Million	211,894 Added 24.38%	1,080,894 $65.2 Million
Q2 2020 Aug 10, 2020	BUY	$54.82 - $64.09 $29 Million - $33.8 Million	528,128 Added 154.93%	869,000 $51.1 Million
Q1 2020 May 11, 2020	SELL	$46.4 - $67.43 $372,824 - $541,800	-8,035 Reduced 2.3%	340,872 $19 Million
Q4 2019 Feb 10, 2020	SELL	$49.21 - $64.19 $1.11 Million - $1.45 Million	-22,546 Reduced 6.07%	348,907 $22.4 Million
Q3 2019 Nov 13, 2019	SELL	$42.77 - $50.71 $142,680 - $169,168	-3,336 Reduced 0.89%	371,453 $18.8 Million
Q2 2019 Aug 13, 2019	SELL	$44.62 - $49.34 $4.26 Million - $4.71 Million	-95,477 Reduced 20.3%	374,789 $0
Q1 2019 May 08, 2019	SELL	$45.12 - $53.8 $9.07 Million - $10.8 Million	-201,045 Reduced 29.95%	470,266 $0
Q4 2018 Feb 11, 2019	BUY	$48.76 - $63.23 $5.61 Million - $7.27 Million	114,958 Added 20.66%	671,311 $34.9 Million
Q3 2018 Nov 09, 2018	BUY	$55.19 - $62.25 $3.47 Million - $3.91 Million	62,836 Added 12.73%	556,353 $0
Q2 2018 Aug 09, 2018	BUY	$50.53 - $62.98 $3.22 Million - $4.01 Million	63,721 Added 14.83%	493,517 $0
Q1 2018 May 11, 2018	BUY	$59.92 - $68.98 $9.93 Million - $11.4 Million	165,667 Added 62.72%	429,796 $0
Q4 2017 Feb 12, 2018	BUY	$59.94 - $65.35 $8.82 Million - $9.61 Million	147,130 Added 125.75%	264,129 $0
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $6.46 Million - $7.46 Million	116,999	116,999 $7.46 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.

Account

Martingale Asset Management L P Bristol Myers Squibb CO Transaction History